Analysts/Institutional Investor Meet/Con. Call Updates

08 August, 2026 To, To, The General Manager, The Manager, Department of Corporate services Listing Department BSE Ltd National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir/ Madam, Sub: Transcript of earnings conference call with Analyst / Investors. In Continuation to our letter dated 28th July 2026, the Company organized a conference call with the Investors/ Analysts on Tuesday, 04th August 2026 at 10:00 AM (IST). A copy of the transcript of the conference call held with the Investors/ Analysts is enclosed herewith and the same has also been uploaded to the Company's Website at https://www.kimshospitals.com/investors > Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015 > Analysts Calls schedule, PPT & Transcripts > Transcripts, Audio & Video Recordings > FY 26-27. Kindly take the same on record. Thanking you, Yours truly For Krishna Institute of Medical Sciences Limited Dr. Bhaskara Rao Bollineni Chairman and Managing Director Encl: As above “KIMS Hospitals Q1 FY '27 Earnings Conference Call” August 04, 2026 MANAGEMENT: DR. BHASKAR RAO BOLLINENI – FOUNDER & MANAGING DIRECTOR, KIMS HOSPITALS DR. ABHINAY BOLLINENI – EXECUTIVE DIRECTOR & CHIEF EXECUTIVE OFFICER, KIMS HOSPITALS MR. SACHIN SALVI – CHIEF FINANCIAL OFFICER, KIMS HOSPITALS MR. NITISH SHETTY – CHIEF EXECUTIVE OFFICER, KIMS BANGALORE CLUSTER MR. SREENATH REDDY – DIRECTOR OF BUSINESS STRATEGY MODERATOR: MR. RAHUL JEEWANI - IIFL CAPITAL SERVICES LIMITED Page 1 of 22 KIMS Hospitals August 04, 2026 Moderator: Ladies and gentlemen, good day, and welcome to the KIMS Hospitals Q1 FY '27 Earnings Conference Call hosted by IIFL Capital Services Limited. As a reminder, all participant lines will remain in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal the operator by pressing ‘*’ then ‘0’ on your touch-tone telephone. Please note that this conference is being recorded. I will now hand the conference over to Mr. Rahul Jeewani from IIFL Capital Services Limited for opening remarks. Thank you, and over to you, Rahul. Rahul Jeewani: Thanks, Ryan. Hi. Good morning, everyone. This is Rahul from IIFL Capital. I welcome you all to the 1st Quarter Earnings Conference Call of KIMS Hospitals being hosted by IIFL. From KIMS, we have with us today Dr. Bhaskar Rao Bollineni – Founder and Managing Director, Dr. Abhinay Bollineni – Executive Director and CEO, Mr. Sachin Salvi – CFO, Dr. Nitish Shetty – CEO for KIMS Bangalore cluster, and Mr. Sreenath Reddy – Director of Business Strategy. Over to you, sir, for your opening comments. Bhaskar Rao Bollineni: Good morning and a hearty welcome to all of you from KIMS. The breeze of Independence Day is already blowing as the nation is getting ready to celebrate its 80th Independence Day. Let me convey the Independence Day greetings to all of you in advance. Without keeping you waiting, I will straight come to financial and operation results Quarter 1, 2026-2027. I am happy that the growth trajectory continued unabated, and we delivered strong financial and operational results for the quarter. We crossed the INR 1,000 crore mark of revenue in Q3 '25/'26, and the same tempo is continued with gust in the current year. Q1 FY '27 updates: Total revenue of INR 1,196 crore, a growth of 36.1% year-on-year and a 10.3% on quarter-on- quarter basis. EBITDA of INR 240 crore, a growth of 20.1% on year-on-year and 10.9% on quarter-on-quarter basis. EBITDA margin at 20.1% versus 20.27% in Quarter 1 Financial Year '26 and 19.9% in Quarter 4 Financial Year '26. PAT at INR 37 crores in Quarter 1, '27 against INR 85 crore and INR 33 crores in Q1 FY '26 and Q4 FY '26 respectively. Page 2 of 22 KIMS Hospitals August 04, 2026 Consolidated EPS for FY '26 of INR 104, a degrowth of 2.3% on quarter-on-quarter basis. Cash and cash equivalents includes cash, bank balance deposits with maturity less than 12 months and investment in mutual funds at INR 505 crore as on 30th June 2026. Quarter 1, '27 financial highlights - consolidated: Consolidated revenue from operations of INR 1,180 crore, a growth of 35.3% on year-on-year and a 9.8% on quarter-on-quarter basis. Consolidated EBITDA pre-Ind AS of INR 222 crore. There is a growth of 14.6% year-on-year and a 12.9% on quarter-on-quarter basis. Consolidated EBITDA pre-Ind AS and excluding other income of INR 206 crores, a growth of 10.2% on year-on-year and a growth of 10% on quarter-on-quarter basis. Operational highlights – consolidated: Quarter 1 Financial Year '27 updates: Average revenue per operating bed grew by 9.7% and 0.1% on year-on-year and quarter-on- quarter basis respectively. Average revenue per patient grew by 6.8% on year-on-year and a decline of 3.8% on quarter- on-quarter basis. IP volumes, 72,493 grew by 26.6% year-on-year and 14% on quarter-on-quarter basis. The annual growth is 15.4%, that is over the Financial Year 2025. OP volumes 6,58,617 grew by 28.5% year-on-year and 8% on quarter-on-quarter basis. The annual growth is 25.4%, that is over the Financial Year 2025. Thus both IP and OP volumes registered impressive growth. We have other developments. I want to apprise you of the two significant financial initiatives we have undertaken. A Qualified Institutional Placement and a preferential allotment to promoters. The QIP successfully raised INR 1,500 crores and has oversubscribed, demonstrating the deep trust and confidence of institutional investors in the vision of your company. In line with our commitment to financial prudence, INR 1,100 crores of these proceeds have already been utilized to reduce our debt. Furthermore, the preferential allotment to promoters stands at INR 600 crores. Under this arrangement, 25% of the amount is to be infused initially and the balance to be brought in within Page 3 of 22 KIMS Hospitals August 04, 2026 18 months. The significant allotment underscores promoter's strong commitment and a long- term faith in the company's stable future. Together, these two strategic initiatives will substantially strengthen our balance sheet and provide us with the necessary financial leverage to explore new growth opportunities. I am happy to state that we have recently opened one unit in Kerala at Palakkad, taking our presence strength to three units in the state. There is a good potential, and we are confident of good results. I am happy that all the new units are doing well on expected lines. At Mahadevapura, Bangalore operated a break-even less than seven months, and we are EBITDA positive. At Electronic City, Bangalore will expect break-even in next one or two quarters. It has been started a little bit later than the Mahadevapura. Both the units are doing very well. We are very happy that the entire Bengaluru cluster is exponentially doing well. It is gladdening that very complex surgeries, including lung transplants, are taking place in the newly opened centers, which speaks about clinical expertise and infrastructure at these centers. I would like to brief about some exceptional professional accomplishments. Dr. Raghuram, our renowned breast care expert, has achieved his third Guinness World Records title in a short span of 15 months. The latest Guinness World Record title was awarded under a newly created category recognizing innovation in artificial intelligence enabled holographic health education. The initiative demonstrates the transformative potential of artificial intelligence and immersive communication in advancing public health awareness. Last month, Dr. Raghuram addressed three distinguished institutions in the U.K. We inaugurated a fully dedicated sports ortho clinic at our Seetamadara, Vizag unit, which is the first of its kind [Showing first 8,000 characters — download PDF for full document]